Stock Market

Tilray (NASDAQ:TLRY) stock could rise or fall in 2023, based on whether American legislators make progress with pro-cannabis bills. While TLRY is a Canadian company, it sells cannabis-related products throughout North America. Thus, U.S. marijuana laws are highly relevant to Tilray and its stakeholders.  So far, this looks like a steep uphill battle, and that’s bad news
There are several reasons why it’s best to steer clear of Alphabet (NASDAQ:GOOG,NASDAQ:GOOGL) shares. Among these various reasons, a key one that could affect the future performance of GOOG stock is rising competition. High competition is having a greater impact on Alphabet’s cloud computing and streaming segments. However, not even its bread-and-butter search advertising segment
While it’s always risky to go against the masses, certain short-squeeze stocks for contrarians to consider may perform surprisingly well. Invariably, even the collective sometimes gets things wrong. Certainly, if everyone bets on the same horse, the subsequent individual reward (if any) would be significantly limited. And that’s part of the reason why going against
In 2022, I was able to greatly reduce my stock portfolio’s losses by shorting several U.S. equities. I found it fairly easy to find favorable stocks to short, as the valuations of many companies were ridiculously high last year, and many stocks were pricing in scenarios that almost certainly would never materialize. For example, I
Shares in SoFi Technologies (NASDAQ:SOFI) have traded sideways over the past month. This is not surprising, given there have not been too many headlines about SOFI stock, since the short-lived excitement surrounding news of insider buying by CEO Anthony Noto. That said, there is something on the horizon that will likely bring this fintech stock
For investors in a wide swath of companies, 2022 was a rough year. That said, it was a downright brutal year for those invested in most tech companies. Indeed, the three stocks on this list are among the mega-cap juggernauts of the tech world. With market capitalizations ranging from $335 billion to more than $2
Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their relevance is recession-proof. With growing demand for gene therapies, immune oncology, and precision medicine, biotech companies have a unique opportunity to impact the world
Hardly anyone, including the company’s fans, would call California-based neo-banking firm SoFi Technologies (NASDAQ:SOFI) a winner in 2022. SOFI stock lost a great deal of value that year, but this could be a setup for a multi-bagger recovery. Indeed, at least one Wall Street expert sees a favorable reward-to-risk ratio for SoFi Technologies’ investors. So,
After a bruising 2022, how will electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) treat its loyal investors during the next 12 months? It’s hard to envision a strong bull case for LCID stock as there no clear positive catalysts. Lucid did raise capital recently, but it wasn’t “free money” by any means. Moreover, the automaker’s
Excitement over recent insider buying has cooled down, but there’s something else that may have some investors interested in SoFi Technologies (NASDAQ:SOFI) stock. SOFI has been affected by many factors, but the continued “student loan saga” has played a major role in the fintech stock’s slump over the past six months. This “saga” will come
To put it bluntly, Meta Materials (NASDAQ:MMAT) investors got the ground-and-pound treatment last year. It certainly didn’t help to lift anyone’s spirits when a notable stakeholder divested tens of thousands of shares of MMAT stock. On the other hand, it’s still a good idea to start a small position in Meta Materials. If all goes according